Afuco™ Anti-Human ECSCR ADCC Therapeutic Antibody, ADCC Enhanced
Anti-ECSCR ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. They are antibodies which bind ECSCR and inhibit chemotaxis. The antibodies may bind an epitope QTVPPNSTTM on the extracellular domain of ECSCR. The antibodies, which may be provided as a pharmaceutical composition, may be used to inhibit tumour cell invasion and may be used in the treatment of diseases, for example diseases associated with angiogenesis such as cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-212CL |
| Pricing | Inquiry |
| Host | Chimeric |
| Target | ECSCR |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4 °C, -20°C if preferred |